abrdn Healthcare Investors
Organization details
- Legal name
- abrdn Healthcare Investors
- Former names
- Tekla Healthcare Investors H&Q Healthcare Investors
- Ownership
- Public
- Status
- Active
- Jurisdiction of incorporation
- Massachusetts
- Headquarters city
- Philadelphia
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- HQH
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000805267
- EIN
- 04-6564285
Board of directors
-
Alan R. Goodson · DirectorSince 2026
-
Bill Maher · DirectorSince 2023
-
Chris LaVictoire Mahai · DirectorSince 2026
-
Daniel R. Omstead · Director · PresidentSince 2023
-
Kathleen Goetz · DirectorSince 2024
-
Rose DiMartino · DirectorSince 2023
-
Stephen Bird · DirectorSince 2023
-
Todd Reit · DirectorSince 2023
Board connections
8 of this board's directors also sit on 15 other boards.
- via Bill Maher, Chris LaVictoire Mahai, Daniel R. Omstead, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
- via Bill Maher, Chris LaVictoire Mahai, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
- via Bill Maher, Chris LaVictoire Mahai, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
- via Alan R. Goodson, Chris LaVictoire Mahai and Todd Reit
- via Bill Maher and Todd Reit
- via Bill Maher and Todd Reit
- via Bill Maher and Todd Reit
- via Bill Maher and Todd Reit
- via Alan R. Goodson
- via Kathleen Goetz
- via Bill Maher
- via Todd Reit
- via Todd Reit
- via Todd Reit
- via Todd Reit
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $10,501
- 1 purchase by 1 insider
- Sold, last 12 months
- $4,675
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Alan R. Goodson Director | Open-market sale | −242 | $19.32 | $4,675 |
| Jul 16, 2026 | Chris LaVictoire Mahai Director | Open-market purchase | +501 | $20.96 | $10,501 |
| Jul 16, 2024 | Rose DiMartino Director | Open-market purchase | +1,000 | $18.88 | $18,880 |
| Apr 9, 2024 | Kathleen Goetz Director | Open-market purchase | +525 | $16.42 | $8,621 |
| Jan 2, 2024 | Todd Reit Director | Open-market purchase | +1,000 | $16.93 | $16,930 |
| Dec 28, 2023 | Bill Maher Director | Open-market purchase | +1,000 | $16.58 | $16,580 |
| Dec 21, 2023 | Goodson Alan R Officer (Vice President) | Open-market purchase | +170 | $16.13 | $2,742 |
| Sep 25, 2023 | Daniel R. Omstead Director, Officer (President) | Open-market purchase | +9,500 | $15.63 | $148,485 |
| Sep 20, 2023 | Daniel R. Omstead Director, Officer (President) | Open-market purchase | +9,500 | $15.88 | $150,860 |
Questions about abrdn Healthcare Investors
How many directors are on abrdn Healthcare Investors's board?
abrdn Healthcare Investors's board has 8 directors: Alan R. Goodson, Bill Maher, Chris LaVictoire Mahai, Daniel R. Omstead, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit.
Are abrdn Healthcare Investors insiders buying or selling shares?
Over the last 12 months, abrdn Healthcare Investors insiders bought $10,501 of shares in 1 purchase and sold $4,675 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="abrdn-healthcare-investors"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.